MedTrace Logo

Sleep Apnea-Hypopnea Syndrome and the Pathogenesis of Obesity

NCT00456651 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2007-04-05

No results posted yet for this study

Summary

The hypothesis of the study is the following: Patients with sleep apnea-hypopnea syndrome have different pattern in the secretion of hormones.

The chronic sleep disorganization that suffer patients with sleep apnea-hypopnea syndrome (SAHS) may affect the central mechanisms that regulate nutritive behavior and energetic balance, causing an alteration in the secretion of hormones that favour the appearance and/or development of obesity.

Conditions

Interventions

DEVICE

CPAP (Continuous Positive Airway Pressure)

Sponsors & Collaborators

  • Fundacion Caubet-Cimera Islas Baleares

    collaborator OTHER

  • Fondo de Investigacion Sanitaria

    collaborator OTHER

  • Sociedad Española de Neumología y Cirugía Torácica

    lead OTHER

Principal Investigators

  • Mónica de la Peña, MD · Hospital Universitario Son Dureta

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00456651 on ClinicalTrials.gov